Alvotech
NASDAQ:ALVODrug Manufacturers - Specialty & Generic
-$0.04 today
- Market cap
- $1.62B
- Beta
- 0.21
- P/E (TTM)
- -15.9
- EPS (TTM)
- -$0.24
Volume 1.56M
Average 0.65M
ALVO EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
AlvotechNASDAQ: ALVO
EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026
EPS (Basic) declines year over year
Q1 FY2026 EPS (Basic) of $0 fell 99.2% year over year, ahead of the -175.0% change in trailing-twelve-month EPS (Basic).
Context
- EPS (Basic) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 4 analysts of -$0.09 (-185.2%) for the fiscal year ending Dec 2026, a slowdown from the +111.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $0+100.8% QoQ
- Last fiscal yearDec 2025
- $0.1+111.5% YoY
- LTMMar 2026
- -$0.28-175.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -99.2% | -147.8% | -48.6 pp |
| 1 year | +111.5% | -185.2% | -296.7 pp |
| 3-year CAGR | — | +66.3% | — |
| 5-year CAGR | +64.3% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- 0.10 USD
- Year-over-year change
- +111.5%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0.10 | +111.5% |
| FY2024 | 2024-12-31 | (0.87) | +64.2% |
| FY2023 | 2023-12-31 | (2.43) | +6.5% |
| FY2022 | 2022-12-31 | (2.60) | +20.0% |
| FY2021 | 2021-12-31 | (3.25) | — |
EPS (Basic) vs competitors
How ALVO compares with its peers on the latest reported figures
- ALVO's LTM Mar 2026 EPS (Basic) of -$0.28 is the 10th highest of the 11 companies compared; the peer median is $1.25.
- Its year-over-year change of -175.0% is the lowest of 11, against a peer median of +33.7%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $41.88 | +0.3% | +2.1% | |
| LTM Jun 2026 | $16.22 | +31.7% | +5.6% | |
| LTM Jun 2026 | $5.68 | -45.9% | -25.0% | |
| LTM Mar 2026 | $2.37 | +69.8% | — | |
| LTM Mar 2026 | $1.71 | -41.4% | +3.8% | |
| LTM Sep 2026 | $0.79 | -59.3% | -41.6% | |
| LTM Jun 2026 | $0.63 | +550.0% | — | |
| LTM Jun 2026 | $0.5 | +4825.7% | — | |
| LTM Mar 2026 | -$0.05 | +71.2% | — | |
| LTM Mar 2026 | -$0.28 | -175.0% | — | |
| LTM Mar 2026 | -$0.39 | +35.7% | — | |
| Peer median (excluding ALVO) | $1.25 | +33.7% | +2.1% | |
Competitors are the stored peer set for ALVO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 36.77M | 83.03M | 91.43M | 489.68M | 586.32M |
| Cost of Revenue | 0 | 64.1M | 160.86M | 185.31M | 235.56M |
| Gross Profit | 36.77M | 18.93M | (69.42M) | 304.37M | 350.76M |
| Gross Margin | 100.0% | 22.8% | -75.9% | 62.2% | 59.8% |
| Research & Development | 191.01M | 180.62M | 210.83M | 171.31M | 184.19M |
| Selling, General & Admin | 84.13M | 186.74M | 73.04M | 61.45M | 90.95M |
| Operating Expenses | 272.23M | 365.38M | 285.44M | 234.73M | 272.56M |
| Depreciation & Amortization | 18.2M | 20.41M | 24.21M | 31.3M | 37.85M |
| EBITDA | (18.03M) | (439.8M) | (493.67M) | (32.28M) | 323.39M |
| EBITDA Margin | -49.0% | -529.7% | -539.9% | -6.6% | 55.2% |
| Operating Income | (235.46M) | (346.44M) | (354.86M) | 69.64M | 78.21M |
| Operating Margin | -640.3% | -417.3% | -388.1% | 14.2% | 13.3% |
| Interest Income | 19K | 912K | 4.82M | 4.62M | 198.49M |
| Interest Expense | 112.97M | 91.44M | 134.82M | 157.6M | 149.19M |
| Other Income / Expenses | 86.26M | (205.21M) | (296.19M) | (287.21M) | 58.14M |
| Income Before Tax | (149.2M) | (551.65M) | (651.05M) | (217.56M) | 136.35M |
| Pre-Tax Margin | -405.7% | -664.4% | -712.0% | -44.4% | 23.3% |
| Income Tax Expense | (47.69M) | (38.07M) | (99.32M) | 14.3M | 108.43M |
| Net Income | (101.5M) | (513.58M) | (551.73M) | (231.86M) | 27.92M |
| Net Margin | -276.0% | -618.6% | -603.4% | -47.3% | 4.8% |
| EPS (Basic) | (3.25) | (2.60) | (2.43) | (0.87) | 0.10 |
| EPS (Diluted) | (3.25) | (2.60) | (2.43) | (0.87) | 0.10 |
| Weighted Avg Shares | 31.25M | 197.72M | 227.26M | 267.92M | 279.19M |
| Weighted Avg Shares (Diluted) | 31.25M | 197.72M | 227.26M | 267.92M | 279.19M |
Alvotech
NASDAQ:ALVO
Intrinsic Alpha fair value
Locked
Current Price
$4.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.